Abstract
A large number of inorganic and organic chemicals act as carcinogens in the liver. Most of these are not active until they are metabolized into short-lived electrophilic forms by the mixed function oxidase systems, e.g., P450 and P448, which is most abundant in the liver. The process of carcinogenesis is initiated when an electrophilic form binds to cellular macromolecules, most importantly DNA, and causes a permanent alteration in the nucleotide sequence. Some of the cells that have been altered in this manner are said to be “initiated”, meaning that they have acquired characteristics which may be expressed in cancer cells (Scherer 1989; Farber 1973; Sell et al. 1987).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Balman A, Pragnell IB (1983) Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303: 72–74
Berger I, Shaul Y (1987) Integration of hepatitis B virus: Analysis of unoccupied sites. J Virol 61: 1180–1186
Beasley RP, Lin CC, Hwang LY, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. A perspective study of 22,707 men in Taiwan. Lancet 2: 1129–1133
Braun A, Carr BI, Hayashi I, Branum EL, Moses HL (1986) Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type B transforming growth factor type B. Proc Natl Acad Sci USA 85: 1539–1543
Braun L, Goyette M, Yaswen P, Thompson NL, Fausto N (1987) Growth in culture and turmorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen treated rats. Cancer Res 47: 4116–4124
Braun L, Mikumo R, Fausto N (1989) Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation. Cancer Res 49: 1554–1561
Brechot CM, Pourcel C, Louise A, Rain B, Tiollais P (1980) Presence of integrated hepatitis B virus DNA sequences in cellular DNA in human hepatocellular carcinoma. Nature 286: 533–535
Brechot CM, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, Tiollais P (1981) State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and- negative liver disease. Proc Natl Acad Sci USA 78: 3906–3910
Brill SJ, DiNardo S, Voelkel-Meiman K, Sternglantz R (1987) Need for DNA topoisomerase I activity as a swivel for DNA replication and for transcription of ribosomal RNA. Nature 326: 414–416
Burgess WH, Maciag T (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58: 575–606
Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D, Czech MP, Ullrich A, Brechot C (1988) Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors and liver tumors and liver cirrhosis. Cancer Res 48: 6844–6849
Chakraborty PR, Ruiz-Opazo N, Shouval D, Shafritz DA (1980) Identification of integrated hepatitis B virus DNA and expression of viral RNA in and HBsAg-producing human hepatocellular carcinoma cell line. Nature 286: 531–533
Champoux JJ (1977) strand breakage by the DNA untwisting enzyme results in the covalent attachment of the enzyme to DNA. Proc Natl Acad Sci USA 74: 3800–3804
Champoux JJ (1978) Mechanism of the reaction catalyzed by the DNA untwisting enzyme: attachment of the enzyme to the 3′-terminus of the nicked DNA. J Mol Biol 118: 441–446
Champoux JJ (1988) Topoisomerase I is preferentially associated with isolated replicating simian virus 40 molecules after treatment of infected cells with camptothecin. J Virol 62: 3675–3683
Champoux JJ, Bullock PA (1988) A possible role for the eucaryotic type I topoisomerase intellegitimate recombination. In: Kucherlapati R, Smith G (eds) Genetic recombination, American Society for Microbiology, Washington, pp 655–656
Chandar N, Lombardi B, Locker J (1989) C-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet. Proc Natl Acad Sci USA 86: 2703–2707
Chen DS, Hoyer BH, Nelson J, Pourcel RH, Gerin JL (1982) Detection and properties of hepatitis B viral DNA in liver tissues from patients with hepatocellular carcinoma. Hepatology 2: 42S–46S
Chisari FV, Ferrari C, Mondelli MU (1989a) Hepatitis B virus structure and biology-mini review. Microbiol Pathog 6: 311–325
Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, and Brinster RL (1987) Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 84: 6909–6913
Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD (1989b) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59: 1145–1156
Colgrove R, Simon G, Ganem D (1989) Transcriptional activation of homologous and heterologous genes by the hepatitis B virus gene product in cells permissive for viral replication. J Virol 63: 4019–4026
DeCaprio J, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275–283
Dejean A, Sonigo P, Wain-Hobson S, Tiollais P (1984) Specific hepatitis B virus integration in hepatocelular carcinoma DNA through a viral 11-base-pair direct repeat. Proc Natl Acad Sci USA 81: 5350–5354
Dejean A, Bougueleret L, Grzeschik K-H, Tiollais P (1986) Hepatitis B virus DNA integration in a sequence homologous tov-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 322: 70–72
DeThe H, Marchio A, Tiollais P (1987) A novel steroid thyroid hormone receptor-related gene in appropriately expressed in human hepatocellular carcinoma. Nature 330: 667–670
Draetta G, Beach D (1988) Activation of cdc2 protein kinase during mitosis in human cells: Cell cycle-dependent phosphorylation and subunit rearrangement. Cell 54: 17–26
Draetta G, Luca F, Westendorf J, Brizuela L, Ruderman J, Beach D (1989) cdc2 protein kinase is complexed with both cyclin a and b: evidence for proteolytic inactivation of mpf. Cell 56: 829–838
Dulak NC, Temin HM (1973) Multiplication-stimulating activity of chicken embryo fibroblasts from rat liver cell conditioned medium: a family of small polypeptides. J Cell Physiol 82: 161–170
Dunsford HA, Sell S (1989) Production of monoclonal antibodies to preneoplastic liver cell populations induced by chemical carcinogens in rats and to transplantable Morris hepatoma. Cancer Res 49: 4984–4900
Dunsford HA, Karnasuta C, Hunt JM, Sell S (1989) Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies. Cancer Res 49: 4894–4900
Edman JC, Gray P, Valenzuela P, Rail LB, Rutter WJ (1980) Integration of hepatitis B virus sequences and their expression in a human hepatoma cell. Nature 286: 535–538
Evarts RP, Nagy P, Marsden E, Thorgeirson S (1987) A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 8: 1737–1740
Farber E (1973) Carcinogenesis-cellular evaluation as a unifying thread: presidential address. Cancer Res 33: 2537–2550
Farber E (1980) Sequential analysis of liver cancer induction. Biochim Biophys Acta 605: 149–166
Farber E (1984) Pre-carcerous steps in carcinogenesis: their physiological adaptive nature. Biochim Biophys Acta 738: 171–180
Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M (1987) Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298–303
Fourel G, Trepo C, Bougueleret L et al. (1990) Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors. Nature 347: 294–298
Francke U, Riccardi VM (1979) Aniridia-Wilms’ tumor association: evidence for specific deletion of 11 p13 Cytogenet Cell Genet 23: 185–192
Friend SH, Dryja TP, Weinberg RA (1989) Oncogenes and tumor-suppressing genes. N Eng J Med 318:618–622
Fu XX, Su CY, Lee Y, Hintz R, Biempica L, Snyder R, Rogler CE (1988) Insulin-like growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers. J Virol 62: 3422–3430
Gilmour DS, Elgin SCR (1987) Localization of specific topoisomerase I interactions within the transcribed region of active heat shock genes by using the inhibitor comptothecin. Mol Cell Biol 17: 141–148
Grandgenett OP, Mumm SR (1990) Unraveling retrovirus integration. Cell 60: 3–4
Greene WC, Leonard J, Wang Y, Svetlik PB, Peffer NJ, Sodorski, JG, Rosen CA, Goh WC, Haseltine WA (1986) Transactivator gene of HTLV-I induces IL-2 receptor and IL-2 cellular gene expression. Science 232: 877–880
Gust ID, Burrell CJ, Coulepis AG et al. (1986) Taxonomic classification of human hepatitis B virus. Intervirology 25: 14–29
Hada H, Arima T, Togawa K, Okada Y, Morichika S, Nagashima H (1986) State of hepatitis B viral DNA in the liver of patients with hepatocellular carcinoma and chronic liver disease. Liver 6: 189–198
Halligan BD, Davis JL, Edwards KA, Liu LF (1982) Intra-and intermolecular strand transfer by HeLa DNA topoisomerase I. J Biol Chem 257: 3995–4000
Hayward WS, Neel BG, Astrin SM (1981) Acivation of a cellular oncogene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290: 475–480
Heard JM, Fichelson S, Sola B, Martial MA, Varet B, Levy JP (1984) Multistep virus-induced leukemogenesis in vitro: description of a model specifying three stems within the myeloblastic malignant process. Mol Cell Biol 4: 216–220
Held WA, Mullins JJ, Kuha NJ, Gallagher JF, Gu GD, Gross KW (1989) T antigen expression and tumorigenesis in transgenic mice containing a mouse major urinary protein/SV40 T antigen hybrid gene. EMBO J 8: 183–191
Hino O, Shows TB, Rogler CE (1986) Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17:18 translocation. Proc Natl Acad Sci USA 83: 8338–8342
Hino O, Ohtake K, Rogler CE (1989) Features of two hepatitis B virus (HBV) DNA integrations suggest mechanisms of HBV integration. J Virol 63:2638–2643
Hixon DC, Allison JP (1985) Monoclonal antibodies recognizing oval cells induced in the liver of rats by N-2-fluorenylacetamide or ehtionine in a choline-deficient diet. Cancer Res 45: 3750–3760
Hixon DC, Fan’s RA, Thompson, NL (1990) An antigenic portrait of the liver during carcinogenesis. Pathobiology 10 (in press)
Hollinger B (1985a) Hepatitis B viruses. In: Fields BN et al. (eds) Virology. Raven, New York, pp 1396–1398
Hollinger B (1985b) Features of viral hepatitis: part I: clinical features. In (eds) Fields BN et al. Virology. Raven, New York pp 1418–1423
Hsu TY, Moroy T, Etiemble J, Louise A, Trepo C, Tiollais P, Buendia M-A (1988) Activation of c-myc by woodchuck hepatitis virus infection in hepatocellur carcinoma. Cell 55: 627–635
Huber BE, Thorgeirson SS (1987) Analysis of c-myc expression in human hepatoma cell line. Cancer Res 47: 3414–3420
Kehule AS, Laurer U, Meyer M, Caselmann WH, Hofschneider, Koshy R (1990) The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343: 457–461
Konopka AK (1988) Compilation of DNA strand exchange sites for nonhomologous recombination in somatic cells. Nucleic Acids Res 16: 1739–1758
Korba BE, Tennant BC, Gowans E et al. (1987) Infection and tissue tropism of WHV during the natural course of viral infection of woodchucks. In: Robinson W, Koike K, Will H (eds) Hepadnaviruses. Liss, New York, pp 419–428
Koshy R, Maupas P, Muller R, Hofschneider PH (1981) Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues. J Gen Virol 57:95–102
Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK (1985) Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 316: 330–334
Lee TH, Finegold MJ, Shen RF et al. (1990) Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 64: 5939–5947
Lombardi B (1982) On the nature, properties and significance of oval cells. In: Pani P, Feo F, Columbano A (eds) Cagliari. ESA, Rome, Italy, pp 36–56
Ludlow JJ, DeCaprio JA, Huang CM, Lee WW, Paucha E, Livingston DL (1989) SV40 large T antigen binds preferentially to an under phasphorylated member of the retinoblastoma susceptibility gene product family. Cell 56: 57–65
Marion PL, Oshiro LS, Regency DC, Scullard GH, Robinson WS (1980) A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci USA 77: 2941–2945
Marion PL, Knight SS, Salazar FH, Popper H, Robinson WS (1983) Ground squirrel hepatitis virus infection. Hepatology 3: 519–527
Marion PL, Van Davelaar MJ, Knight SS, Salazar FH, Garcia G, Popper H, Robinson WS (1986). Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc Natl Acad Sci USA 83: 4543–4546
Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, Inoue J, Yoshida M, Taniguchi T (1987) Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1 encoded p40x and T3/T1 complex triggering. Cell 48: 343–350
Mason WS, Taylor JM (1989) Experimental systems for the study of hepadnavirus and hepatitis delta virus infections. Hepatology 9: 635–645
Mason WS, Seal S, Summers J (1980) Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 36: 829–836
McBurney MW, Reuhl KR, Ally AA, Nasipuri S, Bell JC, Craig J (1988) Differentiation and maturation of embryonyl carcinoma derived neurons in cell culture. J Neurosci 8: 1063–1073
McMahon J, Richard WL, del Campo AA, Song MK, Thorgeirson SS (1986) Differential effects of transforming growth factor B on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res 46: 4665–4671
Mead JE, Fausto N (1989) Transforming growth factor may be a physiological regulator of liver regeneration of means of an autocrine mechanism. Proc Natl Acad Sci USA 86: 1558–1562
Milich DR, Chisari FV (1982) Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg) 1 H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol 129: 320–420
Milich DR, McLachlan A (1986) The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell dependent antigen. Science 234: 1398–1401
Milich DR, Thornton GB, Neurath A (1985) Enhanced immunogenicity of the preS region of hepatitis B surface antigen. Science 228: 1195–1199
Milich DR, McLachlan A, Chisari FV, Kent SBH, Thornton GB (1986) Immune response to the preS (1) region of the hepatitis B surface antigen (HbsAg): a preS (l)-specific T cell response can by-pass nonresponsiveness to the preS (2) and S regions of the HBsAg. J Immunol 137: 315–322
Milich DR, McLachlan A, Thornton GB, Hughes JL (1987) Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329: 547–549
Miller RH, Robinson WS (1986) Common evolutionary origin of hepatitis B virus and retroviruses. Proc Natl Acad Sci USA 83: 2531–2535
Minshull J, Blow JJ, Hunt T (1989) Translation of Cyclin mRNA is necessary for extracts of activated xenopus eggs to enter mitosis. Cell 59: 947–956
Mizusawa H, Taira M, Yaginuma K, Kobayashi M, Yoshida, E, Koike K (1985) Inversely repeating integrated hepatitis B virus DNA and cellular flanking sequences in the human hepatoma-derived cell line huSP. Proc Natl Acad Sci USA 82: 208–212
Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA, Rutter WJ (1987) Insulin-like growth factor II receptor as a multifunctional binding proteins. Nature 329: 301–307
Moroy T, Marchio A, Etiemble J, Trepo C, Tiollais P, Buendia M-A (1986) Rearrangement and enhance depression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature 324: 276–279
Nagaya T, Nakamura T, Tokino T, Isurimoto T, Imai M, Mayumi T, Kamino K, Yamamura K, Matsubara K (1987) The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev 1: 773–782
Nakamura T, Teramoto H, Ichihara A (1986) Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 83: 6489–6493
Nakamura T, Tokino T, Nagaya T, Matsubara (1988) Microdeletion associated with the integration process of hepatitis B virus DNA. Nucleic Acids Res 16: 4865–4873
Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimoniski M, Sugimura A, Tashiro K, Shimizu S (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440–443
Ochiyda T, Fujiyama A, Fukushige S, Hatada I, Matsubara K (1986) Molecular cloning of an oncogene from a human hepatocellular carcinoma. Proc Natl Acad Sci USA 83: 4993–4997
Ogston W, Jonak GJ, Rogler CE, Astrin SM, Summers J (1982) Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks. Cell 29: 385–394
Omato M, Uchiumi K, Ito Y, Yokosuka O, Mori J, Terao K, Wei-Fa Y, O’Connell AP, London W, Okuda K (1983) Duck hepatitis and liver diseases. Gastroenterology 85: 260–267
Pitot HC, Sinca AE (1980) The stages of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta 605: 191–203
Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL (1987) Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 84: 866–870
Radziwill G, Tucker W, Schaller H (1980) Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 64: 613–62
Raimondo G, Burk RD, Lieberman HM, Muschel J, Hadziyannis SJ, Will H, Kew MC, Dusheiko JM, Shafritz DA (1988) Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology 166: 103–112
Rail LB, Scott J, Bell G, Crawford RJ, Penschow JD, Niall HD, Coghlan J (1985) Mouse prepo- epidermal growth factor synthesis by the kidney and other tissues. Nature 313: 228–231
Rechler MM, Nissley PS (1985) The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol 47: 425–422
Reynolds SH, Stowers SJ, Maronpot PR, Anderson M, Aaronson SA (1986) Detection and identification of activated oncogenes in spontaneously benign and malignant HCC’s of B6C3F1 mouse. Proc Natl Acad Sci USA 83: 33–37
Reynolds SH, Stowers SJ, Patterson RM, Maronpot PR, Aaronson SA, Anderson MW (1987) Activated oncogenes in B6C3F1 mouse liver tumors: implications of risk assessment. Science 237: 1309–1316
Rogler CE, Summers J (1982) Novel forms of woodchuck hepatitis virus DNA isolated from chronically infected woodchuck liver nuclei. J Virol 44: 852–863
Rogler CE, Summers J (1984) Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from a chronically infected liver. J Virol 50: 832–837
Rogler CE, Sherman M, Su CY, Shafritz DA (1985) Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science 230: 319–322
Romanus JA, Terrell JW, Yang YW, Nissley P, Rechler M (1986) Insulin-like growth factor carrier proteins in neonatal and adult rat serum and immunologically different. Endocrinology 118: 1743–1757
Ruley HE (1983) Adenovirus early version 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304: 602–603
Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL (1989) Oncogene-induced liver noeplasia in transgenic mice. Oncogene 4: 715–724
Scherer E (1989) Neoplastic progression during or in experimental hepato-carcinogenesis. Biochim Biophys Acta 738: 219–236
Sell S (1978) Distribution of alphafetoprotein and albumin containing cells in the livers of Fischer rats fed four cycles of N-2-fluorenylacetamide. Cancer Res 38: 3107–3113
Sell S, Salman J (1984) Light and electron microscopic autoradiographic analysis of proliferating cells during the early stages of chemical carcinogenesis in the rat induced by feeding N-2-fluorenylacetamide in a choline deficient diet. Am J Pathol 114: 287–300
Sell S, Osborn K, Leffert HL (1981) Autoradiography of “oval cells’ appearing rapidly in the livers of rats fed N-2 fluorenylacetamide in a choline devoid diet. Carcinogenesis 2: 7–14
Sell S, Hunt JM, Knoll BJ, Dunsford HA (1987) Cellular events during hepatocarcinogenesis and the question of premalignancy. Adv Cancer Res 48: 37–111
Seto E, Mitchell PJ, Yen TSB (1990) Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344: 72–74
Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC (1981) Integration of hepatitis virus DNA into the genome of iver cell in chronic liver disease and hepatocellular carcinoma. N Engl J Med 305: 1067–1073
Shaul Y, Ziemer M, Garcia PD, Crawford R, Hsu H, Valenzuela P, Rutter WJ (1984) Cloning and analysis of integrated hepatitis virus sequences from a human hepatoma cell line. J Virol 51:776–787
Shih C, Burke K, Chow MJ, Zeldis JB, Yang CS, Lee CS, Isselbacher KJ, Wands JR, Goodman HM (1987) Tight clustering of human hepatitis B virus integration sites in hepatomas near a triplestranded region. J Virol 61: 3491–3498
Snyder RL, Summers J (1980) Woodchuck hepatitis virus and hepatocellular carcinoma from viruses in naturally occurring cancers. In: Essex M, Todaro G, Zur Hausen H (eds), Cold Spring Harbor Conference of Cell Proliferation, vol 7. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 447–457
Soares MB, Ishii DN, Efstratiadis A (1985) Developmental and tissue-specific expression of a family of transcripts related to rat insulin-like growth factor II mRNA. Nucleic Acids Res 14: 1119–1134
Soares MB, Turken A, Ishii D, Mills L, Epeskopou V, Cotter S, Zeitlin S, Efstratiadis A (1986) Rat insulinlike growth factor II gene, a single gene with two promoters expressing a multitranscript family. J Mol Biol 192: 737–753
Sobczak J, Mechti N, Francoise-Tourmer M, Blanchard JM, Duguet M (1989) C-myc and C-fos gene regulation during mouse liver regeneration. Oncogene 4: 1503–1508
Spandau DF, Lee CH (1988) Trans-activation of viral enhances by the hepatitis B virus X protein. J Virol 62: 427–434
Sprengel R, Kaleta EF, Will H (1988) Isolation and characterization of a hepatitis B virus endemic in herons. J Virol 62: 3832–3839
Summers J, Smolec J, Snyder R (1978) A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 75: 4533–4537
Summers J, Smolec JM, Weiner BG, Kelly TJ, Tyler GW, Snyder RL (1980) Hepatitis B virus and woodchuck hepatitis virus are members of a novel class of DNA viruses from viruses. In: Essex M, Todaro G, Zur Hansen H (eds) Naturally occurring cancers book A, pp 459–469 (Cold Spring Harbor Conference in Cell Proliferation, vol 7)
Takada S, Koike K (1989) Activated N-ras gene was found inhuman hepatoma tissue but only in a small fraction of the tumor cells. Oncogene 4: 189–193
Takada S, Goth Y, Hayasti S, Yostida M, Koike K (1990) Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues. J Virol 64: 822–828
Thompson NL, Mead JE, Braun L, Goyette M, Shank PR, Fausto N (1986) Sequential protooncogene expression during rat liver regeneration. Cancer Res 46: 3111–3117
Tokino T, Fukushige S, Nakamua T, Nagaya T, Murotsu T, Shiga K, Aoki N, Matsubara K (1987) Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinoma. J Virol 61: 3848–3854
Twu JS, Robinson WS (1989) Hepatitis B virus X gene can transactivate heterologous viral sequences. Proc Natl Acad Sci USA 86: 2046–2050
Twu JS, Schloemer RH (1987) Transcriptional transacting function of hepatitis B virus. J Virol 61: 3448–3453
Ueno T, Takahashi K, Matsuguchi T, Endo H, Yamamoto M (1988a) Transcriptional deviation of the rat insulin-ike growth factor II gene initiated at three alternative leader—exons between neonatal tissues and acites hepatomas. Biochim Biophys Acta 950: 411–419
Ueno T, Takahashi K, Matsuguchi T, Ikejiri K, Endo H, Yamamoto M (1988b) Reactivation of rat insulin-like growth factor II gene during hepatocarcinogenesis. Carcinogenesis 9:1779–1783
Wang HP, Rogler CE (1988) Deletions in chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet 48: 72–78
Wang HP, Rogler CE (1991) Topoisomerase I mediated hepadnavirus DNA integration in vitro. J Viral (in press 1991)
Wang J, Chenwesse X, Henglein B, Brechot C (1990) Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343: 555–557
Wollersheim M, Debelka U, Hofschneider PH (1988) A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3: 545–554
Wong S, Winchell LF, McCune BK, Earp H, Teixido S, Massague J, Herman B, Lee DC (1989) The TGF-precursor expressed on the cell surface binds to the EGF receptor on adjacent cells leading to signal transduction. Cell 56: 495–506
Wong-Staal F, Gallo RC (1985) Human T-lymphotropic retroviruses. Nature 317: 395–403
Wu J, Zhou Z-Y, Judd A et al. (1990) The hepatitis B virus-encoded transcriptional activator Hbx appears to be a novel protein serine/threonine kinase. Cell 63: 687–695
Yaginuma K, Kobayashi M, Yoshida E, Koike K (1985) Hepatitis B virus integration in hepatocellular carcinoma DNA: Duplication of cellular flanking sequences at the integration site. Proc Natl Acad Sci USA 82: 4458–4462
Yaginuma K, Kobayashi H, Kobayashi M, Morishima T, Matsuyama K, Koike K (1987) Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children. J Virol 61: 1808–1813
Yang DY and Rogler CE (1991) Insulin-like growth factor (IGF-II) and mannose-6-phosphate/IGF-ll receptor expression in neoplastic nodules and hepatocellular carcinomas: A potential autocrine role in malignant progression in the liver. Cancer Research (in press)
Yokosuka O, Omata M, Zhou YZ, Imazeki F, Okuda T (1985) Duck hepatitis B virus DNA in liver and serum of Chinese ducks: integration of viral DNA in a hepatocellular carcinoma. Proc Natl Acad Sci USA 82: 5180–5184
Zahm P, Hofschneider PH, Koshy R (1988) The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 3: 169–177
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin·Heidelberg
About this chapter
Cite this chapter
Rogler, C.E. (1991). Cellular and Molecular Mechanisms of Hepatocarcinogenesis Associated with Hepadnavirus Infection. In: Mason, W.S., Seeger, C. (eds) Hepadnaviruses. Current Topics in Microbiology and Immunology, vol 168. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76015-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-76015-0_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76017-4
Online ISBN: 978-3-642-76015-0
eBook Packages: Springer Book Archive